Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients

BACKGROUND: Vaccine‐induced thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus‐based vaccines aimed to prevent and minimize COVID‐19 and related pathophysiology. OBJECTIVES: To describe patterns of testing for anti‐platelet factor 4 (PF4) antibodies using various ELISA assays in...

Descripción completa

Detalles Bibliográficos
Autores principales: Favaloro, Emmanuel J., Clifford, Joanne, Leitinger, Emma, Parker, Michael, Sung, Pauline, Chunilal, Sanjeev, Tran, Huyen, Kershaw, Geoffrey, Fu, Suki, Passam, Freda, Ahuja, Monica, Ho, Shir Jing, Duncan, Elizabeth, Yacoub, Olivia, Tan, Chee Wee, Kaminskis, Lisa, Modica, Natasha, Pepperell, Dominic, Ballard, Leanne, Clarke, Lisa, Lee, Christine S.M., Gardiner, Elizabeth E., Young‐Ill Choi, Philip, Tohidi‐Esfahani, Ibrahim, Bird, Robert, Brighton, Timothy, Chen, Vivien M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828670/
https://www.ncbi.nlm.nih.gov/pubmed/36107495
http://dx.doi.org/10.1111/jth.15881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828670/
https://www.ncbi.nlm.nih.gov/pubmed/36107495
http://dx.doi.org/10.1111/jth.15881

Ejemplares similares